Zynlonta 79952-0110
Generic: Loncastuximab Tesirine
Product NDC
79952-0110- Manufacturer
- Adc Therapeutics America, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA761196
Need to source Zynlonta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Loncastuximab Tesirine | 10 mg/2mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) / 2 mL in 1 VIAL, SINGLE-DOSE